Clinical Trials
- Digestive System
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
- Ages12 years - 75 years
- GenderBoth
- Date04/09/2021
- Heart/Cardiovascular, Infectious Disease
Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase (DISRUPT)
- Ages12 years and older
- GenderBoth
- Date01/22/2021
- Diabetes
Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
- Ages12 years - 24 years
- GenderBoth
- Date07/29/2021